67 filings
Page 3 of 4
8-K
ghkvpe8w0zqp4xk
11 May 21
Applied Therapeutics Reports First Quarter 2021 Financial Results
7:24am
8-K
iqkszjxxrvg67d19uhie
18 Mar 21
Applied Therapeutics Reports Fourth Quarter and Year-end 2020 Financial Results
7:22am
8-K
cu5cwdz5wcikjaz99
17 Feb 21
Entry into a Material Definitive Agreement
5:05pm
8-K
zmuiz71b09wlhgl
12 Nov 20
Applied Therapeutics Reports Third Quarter 2020 Financial Results
7:07am
8-K
9sesmu qs5
17 Aug 20
Other Events
8:25am
8-K
vpy 8kr7f
11 Aug 20
Applied Therapeutics Reports Second Quarter 2020 Financial Results
7:07am
8-K
xawp1k0
5 Jun 20
Departure of Directors or Certain Officers
4:48pm
8-K
p2o17u2
26 May 20
Departure of Directors or Certain Officers
8:09am
8-K
uyqio6
11 May 20
Applied Therapeutics Reports First Quarter 2020 Financial Results
7:07am
8-K
x3z877kphmlhd
21 Apr 20
Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial
7:29am
8-K
wuhzr cf5p0
1 Apr 20
Departure of Directors or Certain Officers
5:11pm
8-K
ud0uyogx
13 Mar 20
Applied Therapeutics Reports Fourth Quarter and Year-end 2019 Financial Results
7:01am
8-K
xx2g3eo9p44iggvb9d3
14 Feb 20
Other Events
5:02pm
8-K
fuvn58yg8z0i59y2p8gk
13 Nov 19
Applied Therapeutics Reports Third Quarter 2019 Financial Results
7:15am
8-K
g2seo0 mho4bhf85u
12 Nov 19
Applied Therapeutics, Inc. Announces Pricing of $20 Million Private Placement of Common Stock
9:24am
8-K
w0outdm314bb
4 Sep 19
Departure of Directors or Certain Officers
5:06pm
8-K
2exwkn4 xyrezl
4 Sep 19
Other Events
8:00am
8-K
73bsjb
12 Aug 19
Applied Therapeutics Reports Second Quarter 2019 Financial Results
7:16am
8-K
ew5zx8uyhsr
8 Aug 19
Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia Study
7:00am
8-K
q2568vm50qq7bjc w1ej
6 Aug 19
Regulation FD Disclosure
8:10am